MedPath

Early Assisted Discharge for COPD Exacerbations With Telemonitoring.

Not Applicable
Completed
Conditions
COPD Exacerbation
Interventions
Procedure: Telemonitoring and telephone control
Registration Number
NCT01951261
Lead Sponsor
Dr. López Viña
Brief Summary

To determine if an early assisted discharge program for acute exacerbations of COPD (AECOPD), with telemonitoring and telephone control, is equally effective and more efficient in terms of use of health care resources, that a home care provided by hospital respiratory nurses and pulmonologists.

Detailed Description

This study seeks to improve the health of patients with AECOPD by home care after discharge from the Hospital using the technology of the information and the communication. The investigators want evaluate the efficiency, satisfaction (patients, keepers) and effectiveness of a program of early discharge with home care in patients with AECOPD with telemonitoring and telephone control, in relation to the traditional protocol of home care based on nurse and pulmonologist visits.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
116
Inclusion Criteria
  • Patients admitted to the hospital with COPD exacerbation
  • No concomitant serious unstable diseases
  • Without fever in 48 hours
  • Aerosol treatment at the most every 6 hours
  • Treatment with glucocorticoid intravenous < 40 mg twice a day
  • A thoracic radiograph without new disease
  • Subjective improvement of the patient
  • Familiar suitable environment
Exclusion Criteria
  • Neoplasias and other chronic diseases in terminal situation
  • Alcoholism
  • Intravenous medication
  • Disability to understand and take part in the program
  • Admitted to intensive care unit (ICU) or non invasive mechanical ventilation during the exacerbation
  • Unstability hemodynamic
  • To be an institutionalized patient.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
telemonitoring and telephone controlTelemonitoring and telephone controlEarly discharge from hospital with telemonitoring, telephone control and three nurse scheduled visits.
Primary Outcome Measures
NameTimeMethod
Time Until the First ExacerbationChange from stable to exacerbation the first time at 6 month

Time until the first exacerbation is the time that patient is stable before a new exacerbation and meaning a good control of the disease.

Secondary Outcome Measures
NameTimeMethod
SATISFAD 10Participants will be followed for the duration home care, an expected average of 7 days

Instrument that evaluates satisfaction with home care services in a self-administered. The score ranges from 0 to 30, with the worst value being zero and the best value being 30.

State-Trait Anxiety Inventory (STAI)Participants will be followed for the duration of home care, an expected average of 7 days

The structure of the scale resulting from the combination of item polarity dimensions and the original two factors (State and Trait Anxiety).

Minimum value 0, maximum value 120. Lower score indicates higher anxiety.

Percentage of Participants With Medication Adherence Assessed Using Morinsky-Green-Levine TestParticipants will be followed for the duration of home care up 24 weeks

Consists of a series of 4 contrasting questions with answers dichotomous yes / no, reflecting the patient's behavior regarding compliance with medication. They are intended to assess whether the patient adopts correct attitudes regarding treatment for his illness; it is assumed that if attitudes they are incorrect the patient is non-compliant.

Monitoring ComplianceParticipants will be followed for the duration of home care, an expected average of 7 days

It represents the compliance of the patients with respect to the sending of constants through the telemedicine monitor that should be (following the protocol) at least twice a day. The patient was considered compliant if he sent the constant at least 2 twice a day or non-compliant otherwise.

Number of Home VisitsParticipants will be followed for the duration of home care, an expected average of 7 days
COPD Assessment Test (CAT)Participants will be followed for the duration of home care and up to 4 weeks

It's a simple questionnaire for assessing and monitoring COPD. It quantifies chronic obstructive pulmonary disease (COPD) impact in routine practice to aid health status assessment.

It's self-administered in 2 min. It consists of 8 items that measure aspects of cough, expectoration, chest tightness, dyspnea, domestic activities, self-confidence, sleep and energy. Each section is scored from 0 to 5 and therefore a maximum of 40 points can be obtained; a higher score indicates a greater negative impact of COPD. Significant clinical changes correspond to a variation of 2 points or more.

Trial Locations

Locations (1)

Universitary Hospital Puerta de Hierro.

🇪🇸

Majadahonda, Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath